Literature DB >> 21840911

Hormonal contraception and mental health: results of a population-based study.

E Toffol1, O Heikinheimo, P Koponen, R Luoto, T Partonen.   

Abstract

BACKGROUND: The effects of oral contraceptives (OCs) on mental health are not clear, and no study has been focused on the effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) on mental health. The aim of this study was to analyse the association between the use of OCs and the LNG-IUS and psychological well-being and psychopathology.
METHODS: The associations between the current use of OCs and the LNG-IUS, and their duration versus mood symptoms [Beck Depression Inventory (BDI)], psychological well-being [(General Health Questionnaire-12 (GHQ-12)] and recent psychiatric diagnoses [(Composite International Diagnostic Interview (CIDI)] were examined among women who participated in the Finnish-population-based Health 2000 study. Analyses were performed on the 30- to 54-year-old sample (n = 2310); some of the analyses were extended to include the younger age group (18- to 54-year-old sample; n = 3223).
RESULTS: Overall, hormonal contraception was well tolerated with few significant effects on psychological well-being. The length of OC use was inversely associated with some BDI items ('dissatisfaction, irritability, lost interest in people, earlier waking and lost interest in sex'), and directly associated with 'worries about one's health' (BDI) and with a current diagnosis of 'alcohol dependence' (CIDI). The current use of the LNG-IUS was inversely associated with 'earlier waking' (BDI) and with 'impaired concentration' (GHQ), while the length of LNG-IUS use was inversely associated with 'strain' (GHQ).
CONCLUSIONS: The influence of hormonal birth control on mental health is modest and mainly favourable. The length of current OC use seems to have some beneficial effects on mood although the longer the duration of use, the greater the association with a diagnosis of alcohol dependence. Knowledge of the use of hormonal contraception might be of value when assessing psychopathology in women. The cross-sectional design, with partly retrospective data collection, precludes any causal conclusions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840911     DOI: 10.1093/humrep/der269

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  18 in total

1.  Commentary: De Novo Self-Mutilation and Depressive Symptoms in a 17-year-old Adolescent Girl Receiving Depot-Medroxyprogesterone Acetate.

Authors:  Elena Toffol; Oskari Heikinheimo; Timo Partonen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-02

Review 2.  Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review.

Authors:  Mishka Terplan; Dennis J Hand; Melissa Hutchinson; Elizabeth Salisbury-Afshar; Sarah H Heil
Journal:  Prev Med       Date:  2015-04-18       Impact factor: 4.018

Review 3.  Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research.

Authors:  Thalia Robakis; Katherine E Williams; Lexi Nutkiewicz; Natalie L Rasgon
Journal:  Curr Psychiatry Rep       Date:  2019-06-06       Impact factor: 5.285

4.  Oral contraceptive use and depression among adolescents.

Authors:  Sarah McKetta; Katherine M Keyes
Journal:  Ann Epidemiol       Date:  2018-10-13       Impact factor: 3.797

5.  Oral contraceptive use and psychiatric disorders in a nationally representative sample of women.

Authors:  Keely Cheslack-Postava; Katherine M Keyes; Sarah R Lowe; Karestan C Koenen
Journal:  Arch Womens Ment Health       Date:  2014-08-13       Impact factor: 3.633

6.  Highly Effective Birth Control Use Before and After Women's Incarceration.

Authors:  Megha Ramaswamy; Hsiang-Feng Chen; Karen L Cropsey; Jennifer G Clarke; Patricia J Kelly
Journal:  J Womens Health (Larchmt)       Date:  2015-01-02       Impact factor: 2.681

7.  Depression in Female Adolescents with Heavy Menstrual Bleeding.

Authors:  Angela C Weyand; Kate D Fitzgerald; Mary McGrath; Vibhuti Gupta; Thomas M Braun; Elisabeth H Quint; Sung W Choi
Journal:  J Pediatr       Date:  2021-09-10       Impact factor: 6.314

8.  Stable Anxiety and Depression Trajectories in Late Adolescence for Oral Contraceptive Users.

Authors:  Anne Marieke Doornweerd; Susan Branje; Stefanie A Nelemans; Wim H J Meeus; Estrella R Montoya; Iris M Engelhard; Joke M P Baas; Lotte Gerritsen
Journal:  Front Psychiatry       Date:  2022-05-23       Impact factor: 5.435

9.  Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

Authors:  Katherine M Keyes; Keely Cheslack-Postava; Carolyn Westhoff; Christine M Heim; Michelle Haloossim; Kate Walsh; Karestan Koenen
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

10.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.